• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/18

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

18 Cards in this Set

  • Front
  • Back
stimulate pancreas to produce more insulin (for patients with some pancreatic production)
SE: hypoglycemia
Type I
sulfonylureas
glipizide
glyburide
glimerpiride
slow carbohydrate digestion
SE: cramps, borborygamus, flatus
Type I and II
a-glucosidase inhibitor
acarbose
miglitol
stimulated pancreatic insulin production
SE: hypoglycemia
Type II
meglitinides
repanglinide
nateglinide
dec liver produc of gluc, inc muscle us of sugar
SE: nasea, diarrhea, dec appet, lactic acidosis
Type I and II
biguanides:
metformin
dec insulin resistance
SE: hypoglycemia, inc risk for heart failure
Type I and II
Thiazolidinediones:
rosiglitazone
pioglitazone
short acting insulin
onset 30 min
peak 2-4 hours
duration 5-8 hours
regular insulin
rapid acting insulin
action: 5-15 min
peak 45-75 min
duration 2-4 hours
insulin...
lispro
aspart
glulisine
3 healthy people 2010 objectives for DM
dec DM death rates
dec frequency of foot ulcer
inc to 52% patient formal DM education
DM Dx
2 fasting > 126
Dx preDM
2 fasting 100-125
macrovascular changes dt DM
MI
stroke
PAD
microvascular changes dt DM
retinopathy (mini-hemhorages)
microalbuminuria (dsyfx glomerulus spill proteins)
2nd most common reason for liver transplants in the US
acetominphen related liver failure
5 reasons for medical intervention in DM
replace insulin
inc insulin production
dec insulin resistance
dec release of stored glucose
alter nutrient absorbtion
3 glucose related emergencies
DKA ( lack of insulin and ketosis)
HHNS (insulin defic and dehydration)
hypoglycemia
long acting insulin:
NPH
glargine
Detemir
onset all 2 h
peak : 6-10 h NPH, no peak glargine and detemir
duration: 18-28,20- >24, 6-24 hours
HP 2010 for arthritis
inc adults who have seen PCP for chronic joint Sx
inc those w/arthritis evidence based education
HP:2010 osteoporosis
dec numb of adults hospitalized with vertebral fractures dt osteop